Trending Stock News

Strategic Advisors Lifted Johnson & Johnson (JNJ) Holding By $310,016; Abercrombie & Fitch Co (ANF) Sentiment Is 1.03

Abercrombie & Fitch Co. (NYSE:ANF) Logo

Strategic Advisors Llc increased Johnson & Johnson (JNJ) stake by 4.4% reported in 2018Q1 SEC filing. Strategic Advisors Llc acquired 2,422 shares as Johnson & Johnson (JNJ)’s stock declined 8.03%. The Strategic Advisors Llc holds 57,405 shares with $7.36M value, up from 54,983 last quarter. Johnson & Johnson now has $325.59 billion valuation. The stock decreased 0.53% or $0.65 during the last trading session, reaching $121.39. About 1.68 million shares traded. Johnson & Johnson (NYSE:JNJ) has declined 4.75% since June 21, 2017 and is downtrending. It has underperformed by 17.32% the S&P500. Some Historical JNJ News: 09/05/2018 – Kames Adds Praxair, Exits AO Smith, Cuts J&J: 13F; 12/04/2018 – Johnson & Johnson’s Janssen: INVOKANA Showed Significant Renal Protective Benefits in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease; 05/04/2018 – J&J ORDERED TO PAY $37 MILLION OVER BANKER’S TALC CANCER CLAIMS; 25/05/2018 – J&J Jury Asks Judge to Slap Cancer Warning Label on Baby Powder; 07/03/2018 – IFM Therapeutics and Bristol-Myers Squibb Awarded 2017 Deal of the Year by Clarivate Analytics; 17/04/2018 – JNJ: PHARMA SEGMENT IS DRIVING UPBEAT OUTLOOK FOR 2018; 06/04/2018 – Johnson & Johnson Vision Highlights New Data, Educational Resources and Support for the Ophthalmology Community at the 2018 ASCRS•ASOA Annual Meeting; 15/03/2018 – J&J’s blockbuster hopeful erdafitinib gets ‘breakthrough’ moniker $JNJ @BrittanyMeiling; 18/04/2018 – KENTUCKY SUES JOHNSON & JOHNSON, ACCUSES COMPANY OF DEVISING DECEPTIVE OPIOID MARKETING SCHEME; 12/04/2018 – INVOKANA® (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

Abercrombie & Fitch Co (ANF) investors sentiment decreased to 1.03 in 2018 Q1. It’s down -0.20, from 1.23 in 2017Q4. The ratio worsened, as 109 investment managers increased or started new equity positions, while 106 decreased and sold their positions in Abercrombie & Fitch Co. The investment managers in our database now hold: 67.61 million shares, down from 69.17 million shares in 2017Q4. Also, the number of investment managers holding Abercrombie & Fitch Co in top ten equity positions increased from 2 to 3 for an increase of 1. Sold All: 32 Reduced: 74 Increased: 59 New Position: 50.

Analysts await Abercrombie & Fitch Co. (NYSE:ANF) to report earnings on August, 23. They expect $-0.11 EPS, up 31.25% or $0.05 from last year’s $-0.16 per share. After $-0.56 actual EPS reported by Abercrombie & Fitch Co. for the previous quarter, Wall Street now forecasts -80.36% EPS growth.

Abercrombie & Fitch Co., through its subsidiaries, operates as a specialty retailer. The company has market cap of $1.90 billion. The Firm operates through two divisions, Abercrombie and Hollister. It has a 73.89 P/E ratio. It offers knit tops, woven shirts, graphic T-shirts, fleece, sweaters, jeans, woven pants, shorts, outerwear, dresses, intimates, and swimwear; and personal care products and accessories for men, women, and kids under the Abercrombie & Fitch, abercrombie kids, Hollister, and Gilly Hicks brand names.

Since January 1, 0001, it had 1 buying transaction, and 1 sale for $426,349 activity.

More recent Abercrombie & Fitch Co. (NYSE:ANF) news were published by: which released: “Retail sales winners and losers” on June 14, 2018. Also published the news titled: “Good Times Ahead For Abercrombie & Fitch” on June 04, 2018.‘s news article titled: “ABERCROMBIE & FITCH CO. REPORTS FIRST QUARTER RESULTS” with publication date: June 01, 2018 was also an interesting one.

Ratings analysis reveals 9% of Abercrombie & Fitch’s analysts are positive. Out of 11 Wall Street analysts rating Abercrombie & Fitch, 1 give it “Buy”, 3 “Sell” rating, while 7 recommend “Hold”. The lowest target is $13.0 while the high is $21.0. The stock’s average target of $17.60 is -37.32% below today’s ($28.08) share price. ANF was included in 12 notes of analysts from August 30, 2016. The company was downgraded on Wednesday, August 31 by Stifel Nicolaus. The firm has “Sector Perform” rating by RBC Capital Markets given on Wednesday, August 31. The stock of Abercrombie & Fitch Co. (NYSE:ANF) earned “Peer Perform” rating by Wolfe Research on Monday, November 14. Standpoint Research upgraded the shares of ANF in report on Tuesday, August 30 to “Buy” rating. The stock of Abercrombie & Fitch Co. (NYSE:ANF) has “Hold” rating given on Tuesday, January 3 by Jefferies. The firm has “Market Perform” rating by Telsey Advisory given on Wednesday, August 31. As per Wednesday, August 31, the company rating was maintained by FBR Capital. The rating was downgraded by Oppenheimer to “Underperform” on Tuesday, January 3. Deutsche Bank downgraded it to “Sell” rating and $13.0 target in Wednesday, November 23 report. The firm earned “Sector Weight” rating on Thursday, October 6 by KeyBanc Capital Markets.

The stock increased 2.00% or $0.55 during the last trading session, reaching $28.08. About 1.14 million shares traded. Abercrombie & Fitch Co. (ANF) has risen 81.14% since June 21, 2017 and is uptrending. It has outperformed by 68.57% the S&P500. Some Historical ANF News: 07/03/2018 – ABERCROMBIE & FITCH CO – FOR FISCAL 2018, COMPANY EXPECTS NET SALES TO BE UP LOW-SINGLE DIGITS; 07/03/2018 – Abercrombie & Fitch Sees FY18 Net Sales Up Low-Single Digits; 08/03/2018 – S&PGR Revises Abercrombie & Fitch Otlk To Stable From Negative; 28/05/2018 – Civil rights advisers hope Starbucks’ anti-bias training sets example; 08/03/2018 – Abercrombie & Fitch Goes Ex-Dividend, Trades Without Payout; 25/04/2018 – Abercrombie Aims to Be $5B Global Lifestyle Brand; 23/04/2018 – Abercrombie & Fitch Highlights Improved Working Conditions in Bangladesh After Protests; 15/03/2018 – ABERCROMBIE & FITCH OUTLOOK STABLE BY MOODY’S; 25/04/2018 – Abercrombie & Fitch Reader Demand Rises; Options Volume High; 07/03/2018 – Abercrombie’s same-store sales top Street estimates

Sls Management Llc holds 13.59% of its portfolio in Abercrombie & Fitch Co. for 155,300 shares. Paradice Investment Management Llc owns 2.72 million shares or 4.76% of their US portfolio. Moreover, Lesa Sroufe & Co has 3.46% invested in the company for 182,182 shares. The Jersey-based Contrarius Investment Management Ltd has invested 1.61% in the stock. Majedie Asset Management Ltd, a United Kingdom-based fund reported 337,057 shares.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 11 have Buy rating, 5 Sell and 7 Hold. Therefore 48% are positive. Johnson & Johnson had 102 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by BMO Capital Markets with “Buy” on Tuesday, July 18. The firm has “Outperform” rating by RBC Capital Markets given on Wednesday, January 25. Stifel Nicolaus maintained the shares of JNJ in report on Tuesday, July 18 with “Hold” rating. The stock has “Equal-Weight” rating by Barclays Capital on Wednesday, October 18. Alembic downgraded the stock to “Underweight” rating in Friday, July 21 report. As per Tuesday, June 12, the company rating was maintained by Credit Suisse. On Monday, July 10 the stock rating was maintained by RBC Capital Markets with “Buy”. Credit Suisse maintained it with “Buy” rating and $154.0 target in Thursday, October 19 report. BMO Capital Markets maintained it with “Buy” rating and $13200 target in Monday, July 10 report. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by Cowen & Co on Friday, October 6.

Investors sentiment increased to 0.93 in 2018 Q1. Its up 0.06, from 0.87 in 2017Q4. It improved, as 63 investors sold JNJ shares while 831 reduced holdings. 111 funds opened positions while 720 raised stakes. 1.71 billion shares or 0.80% less from 1.72 billion shares in 2017Q4 were reported. Wellington Shields & Ltd Llc has invested 1.64% of its portfolio in Johnson & Johnson (NYSE:JNJ). Welch And Forbes Ltd owns 764,216 shares for 2.52% of their portfolio. Spectrum Asset Mngmt (Nb Ca) has 2,322 shares. 23,316 were reported by Moneta Grp Incorporated Inv Advsrs Lc. Wetherby Asset Mngmt owns 61,871 shares. Groesbeck Investment Mgmt Nj holds 0.19% or 2,000 shares. Bragg Advsrs holds 1.15% or 61,540 shares. Gotham Asset Mngmt Limited Liability Com invested in 390,826 shares or 0.7% of the stock. Hgk Asset Mngmt Incorporated invested in 2.29% or 117,879 shares. Impax Asset Mgmt Limited Liability Company stated it has 166,508 shares or 1.23% of all its holdings. Wealth Enhancement Advisory Services Limited Co stated it has 0.38% in Johnson & Johnson (NYSE:JNJ). 723,640 are held by Blair William & Il. Aull Monroe Investment Mgmt Corporation holds 3.52% or 52,749 shares. Price T Rowe Assoc Inc Md holds 0.42% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 20.71M shares. Federated Invsts Inc Pa stated it has 814,908 shares or 0.3% of all its holdings.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: which released: “Buy Johnson & Johnson” on June 20, 2018, also with their article: “What Are Johnson & Johnson’s Key Sources Of Revenue?” published on June 20, 2018, published: “Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks” on June 20, 2018. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: and their article: “How Do You Feel About Johnson & Johnson?: Part IV – Today’s Editors’ Picks” published on June 01, 2018 as well as‘s news article titled: “Better Buy: Pfizer Inc. vs. Johnson & Johnson” with publication date: June 17, 2018.

Johnson & Johnson (NYSE:JNJ) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *